Article Navigation
- < Previous
- Next >
Journal Article
Get access
, Eberhard Denk Human Nutrition Laboratory, Institute of Food Science and Nutrition, ETH‐Zurich, Zurich, Switzerland Search for other works by this author on: Oxford Academic Darren Hillegonds Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California, USA Search for other works by this author on: Oxford Academic Richard F Hurrell Human Nutrition Laboratory, Institute of Food Science and Nutrition, ETH‐Zurich, Zurich, Switzerland Search for other works by this author on: Oxford Academic John Vogel Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California, USA Search for other works by this author on: Oxford Academic Karin Fattinger Department of General Internal Medicine, Inselspital, University Hospital Bern, Bern, Switzerland Search for other works by this author on: Oxford Academic Hans J Häuselmann Center of Rheumatology and Bone Diseases, Klinik im Park, Zurich, Switzerland Search for other works by this author on: Oxford Academic Marius Kraenzlin Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, University Hospital Basel, Switzerland Search for other works by this author on: Oxford Academic Thomas Walczyk Human Nutrition Laboratory, Institute of Food Science and Nutrition, ETH‐Zurich, Zurich, Switzerland Address reprint requests to: Thomas Walczyk, PhD, Department of Chemistry, Faculty of Science, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 3 Science Drive, Singapore 117543, Singapore Search for other works by this author on: Oxford Academic
Journal of Bone and Mineral Research, Volume 22, Issue 10, 1 October 2007, Pages 1518–1525, https://doi.org/10.1359/jbmr.070617
Published:
04 December 2009
Article history
Received:
20 September 2006
Revision received:
07 March 2007
Accepted:
15 June 2007
Published:
04 December 2009
- Views
- Article contents
- Figures & tables
- Video
- Audio
- Supplementary Data
-
Cite
Cite
Eberhard Denk, Darren Hillegonds, Richard F Hurrell, John Vogel, Karin Fattinger, Hans J Häuselmann, Marius Kraenzlin, Thomas Walczyk, Evaluation of 41Calcium as a New Approach to Assess Changes in Bone Metabolism: Effect of a Bisphosphonate Intervention in Postmenopausal Women With Low Bone Mass, Journal of Bone and Mineral Research, Volume 22, Issue 10, 1 October 2007, Pages 1518–1525, https://doi.org/10.1359/jbmr.070617
Close
Search
Close
Search
Advanced Search
Search Menu
Abstract
A new technique was evaluated to identify changes in bone metabolism directly at high sensitivity through isotopic labeling of bone Ca. Six women with low BMD were labeled with 41Ca up to 700 days and treated for 6 mo with risedronate. Effect of treatment on bone could be identified using 41Ca after 4–8 wk in each individual.
Introduction: Isotopic labeling of bone using 41Ca, a long‐living radiotracer, has been proposed as an alternative approach for measuring changes in bone metabolism to overcome current limitations of available techniques. After isotopic labeling of bone, changes in urinary 41Ca excretion reflect changes in bone Ca balance. The aim of this study was to validate this new technique against established measures. Changes in bone Ca balance were induced by giving a bisphosphonate.
Materials and Methods: Six postmenopausal women with diagnosed osteopenia/osteoporosis received a single oral dose of 100 nCi 41Ca for skeleton labeling. Urinary 41Ca/40Ca isotope ratios were monitored by accelerator mass spectrometry up to 700 days after the labeling process. Subjects received 35 mg risedronate per week for 6 mo. Effect of treatment was monitored using the 41Ca signal in urine and parallel measurements of BMD by DXA and biochemical markers of bone metabolism in urine and blood.
Results: Positive response to treatment was confirmed by BMD measurements, which increased for spine by +3.0% (p = 0.01) but not for hip. Bone formation markers decreased by −36% for bone alkaline phosphatase (BALP; p = 0.002) and −59% for procollagen type I propeptides (PINP;p = 0.001). Urinary deoxypyridinoline (DPD) and pyridinoline (PYD) were reduced by −21% (p = 0.019) and −23% (p = 0.009), respectively, whereas serum and urinary carboxy‐terminal teleopeptides (CTXs) were reduced by −60% (p = 0.001) and −57.0% (p = 0.001), respectively. Changes in urinary 41Ca excretion paralleled findings for conventional techniques. The urinary 41Ca/40Ca isotope ratio was shifted by −47 ± 10% by the intervention. Population pharmaco*kinetic analysis (NONMEM) of the 41Ca data using a linear three‐compartment model showed that bisphosphonate treatment reduced Ca transfer rates between the slowly exchanging compartment (bone) and the intermediate fast exchanging compartment by 56% (95% CI: 45–58%).
Conclusions: Isotopic labeling of bone using 41Ca can facilitate human trials in bone research by shortening of intervention periods, lowering subject numbers, and having easier conduct of cross‐over studies compared with conventional techniques.
41Ca, bisphosphonate, biomarkers, BMD, calcium kinetics
Copyright © 2007 ASBMR
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Issue Section:
research articles
You do not currently have access to this article.
Download all slides
Sign in
Get help with access
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Sign in Register
Institutional access
- Sign in with a library card
- Sign in with username/password
- Recommend to your librarian
Sign in through your institution
Sign in through your institution
Institutional account management
Sign in as administrator
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Purchase
Subscription prices and ordering for this journal
Purchasing options for books and journals across Oxford Academic
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Evaluation of 41Calcium as a New Approach to Assess Changes in Bone Metabolism: Effect of a Bisphosphonate Intervention in Postmenopausal Women With Low Bone Mass1* - 24 Hours access
EUR €46.00
GBP £40.00
USD $49.00
Advertisem*nt
Citations
Views
51
Altmetric
More metrics information
Metrics
Total Views 51
39 Pageviews
12 PDF Downloads
Since 2/1/2024
Month: | Total Views: |
---|---|
February 2024 | 18 |
March 2024 | 19 |
April 2024 | 6 |
May 2024 | 8 |
Citations
Powered by Dimensions
Altmetrics
Email alerts
Article activity alert
Advance article alerts
New issue alert
Receive exclusive offers and updates from Oxford Academic
Email alerts
Advance article alerts
New issue alert
Receive exclusive offers and updates from Oxford Academic
Related articles in
- Google Scholar
Citing articles via
Google Scholar
-
Latest
-
Most Read
-
Most Cited
More from Oxford Academic
Clinical Medicine
Endocrinology and Diabetes
Medicine and Health
Books
Journals
Advertisem*nt